← Back to Search
Behavioural Intervention
Empathetic Communication for Patient Preference
Rochester, MN
N/A
Waitlist Available
Led By April Christensen, MD, MS
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients over the age of 18 being seen in palliative care clinic who have already established care and with diagnosis of any malignancy
Be older than 18 years old
Must not have
Inability to consent defined as: Acute mental status changes (delirium/encephalopathy), acute substance intoxication, intellectual disability, dementia, patient with active legal guardian
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if patients prefer talking to a human or AI for empathetic communication, and whether knowing who is speaking affects their preference.
See full description
Who is the study for?
This trial is for individuals interested in participating in a study about communication preferences. There are no specific inclusion or exclusion criteria provided, which suggests that the study may be open to a broad adult population.Check my eligibility
What is being tested?
The trial is testing patient preferences for empathetic communication authored by AI versus humans. Participants will likely take surveys where they'll evaluate messages without knowing who wrote them and then again with that knowledge.See study design
What are the potential side effects?
Since this study involves taking surveys on communication preferences, there are no direct medical side effects associated with the interventions being tested.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18, seeing a palliative care doctor, and have been diagnosed with cancer.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am able to understand and consent to my own medical treatment.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Preference patterns for empathetic communication
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Survey Group - UnblindedExperimental Treatment1 Intervention
Participants will be informed of origin of survey statements
Group II: Survey Group - BlindedExperimental Treatment1 Intervention
Participants will be blinded to origin of survey statements
Find a Location
Closest Location:Mayo Clinic in Rochester· Rochester, MN· 516 miles
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,411 Previous Clinical Trials
3,208,528 Total Patients Enrolled
April Christensen, MD, MSPrincipal InvestigatorMayo Clinic in Rochester